2-tert-butylhydroquinone has been researched along with Heart Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P; Liu, N; Peng, QS; Ping, S; Shi, WD; Zhou, NQ | 1 |
| Chen, HH; Chen, JJ; Cheng, CF; Juan, SH; Lai, PF; Li, HF; Lin, H | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Heart Failure
| Article | Year |
|---|---|
Tert-butylhydroquinone promotes angiogenesis and improves heart functions in rats after myocardial infarction.
Topics: Androstadienes; Angiogenesis Inducing Agents; Animals; Antioxidants; Cell Movement; Cell Proliferation; Echocardiography; Heart; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Hydroquinones; Hypertension; Male; Myocardial Infarction; Neovascularization, Physiologic; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Wortmannin | 2017 |
Activating transcription factor 3 protects against pressure-overload heart failure via the autophagy molecule Beclin-1 pathway.
Topics: Activating Transcription Factor 3; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cardiotonic Agents; Heart Failure; HEK293 Cells; Humans; Hydroquinones; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Ventricular Function, Left | 2014 |